By P.R. Venkat

Wuxi Biologics (Cayman) Inc. is planing to undertake a stock split aimed at boosting liquidity as well as attracting more investors.

The company is proposing to split one stock into three, Wuxi said Monday.

"The board considers that the share subdivision is fair and reasonable and in the interests of the company and its shareholders as a whole," it said.

The stock split is conditional upon the approval of shareholders at the extraordinary general meeting to be held on or before Oct. 27, the company said.

The share subdivision, upon becoming effective, would increase the total number of shares in issue and reduce the trading price of each share, it said.

Shares of Wuxi on the Hong Kong Exchange closed at 191.10 Hong Kong dollars (US$24.66) a piece on Friday. 



  Write to P.R. Venkat at venkat.pr@wsj.com